PRAIS 2.0 – Page 42 – Regional Platform on Access and Innovation for Health Technologies

HPV testing and single-dose vaccine key to tackle cervical cancer in the Americas, PAHO report says

admin - 15:13, 25 de September de 2024253

HPV testing and single-dose vaccine key to tackle cervical cancer in the Americas, PAHO report says

Cristina Mitchell

26 Sep 2024

Zimmer Biomet CPT Hip System Femoral Stem and Increased Risk of Thigh Bone Fracture – FDA Safety Communication

Murilo Freitas - 04:00, 25 de September de 2024218

Read the FDA’s recommendations related to the Zimmer Biomet CPT Hip System and increased risk of thigh bone fracture.

http://www.fda.gov/medical-devices/safety-communications/zimmer-biomet-cpt-hip-system-femoral-stem-and-increased-risk-thigh-bone-fracture-fda-safety

Director de la OPS destaca la importancia de una respuesta global solidaria y equitativa a la resistencia a los antimicrobianos

admin - 21:44, 24 de September de 2024293

PAHO Director highlights importance of a global, solidarity-based and equitable response to antimicrobial resistance

Cristina Mitchell

25 Sep 2024

PAHO and IDB sign agreement to broaden collaboration

admin - 17:12, 24 de September de 2024207

PAHO and IDB sign agreement to broaden collaboration

Cristina Mitchell

25 Sep 2024

FDA Approves New Drug to Treat Niemann-Pick Disease, Type C

Murilo Freitas - 21:30, 23 de September de 2024218

FDA Approves New Drug to Treat Niemann-Pick Disease, Type C
http://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treat-niemann-pick-disease-type-c

PAHO Director calls for urgent action to eliminate cervical cancer in the Americas

admin - 21:18, 23 de September de 2024220

PAHO Director calls for urgent action to eliminate cervical cancer in the Americas

Cristina Mitchell

24 Sep 2024

FDA Roundup: September 24, 2024

Murilo Freitas - 20:07, 23 de September de 2024193

FDA Roundup: September 24, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-24-2024

Compounding Device Inlet Correction: Baxter Healthcare Corporation Updates Use Instructions for Exactamix Automated Compounding Device Inlets due to Risk for Particulate Matter in Device Components

Murilo Freitas - 04:00, 23 de September de 2024297

Automated Compounding Device Inlets used with Exactamix Compounding Devices may contain particulate matter that poses a risk to patients.

http://www.fda.gov/medical-devices/medical-device-recalls/compounding-device-inlet-correction-baxter-healthcare-corporation-updates-use-instructions-exactamix

PAHO and CEPI to advance regulatory harmonization and response to health emergencies in the Americas

admin - 17:41, 22 de September de 2024259

PAHO and CEPI to advance regulatory harmonization and response to health emergencies in the Americas

Cristina Mitchell

23 Sep 2024

rss rss-es rss-pt

Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) for Injection 100 mg/vial Due to the Presence of a Glass Particle

Murilo Freitas - 04:00, 22 de September de 20242,311

Foster City, Calif., September 20, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is issuing a voluntary recall of one lot of Veklury® (remdesivir) for Injection 100 mg/vial, to the consumer level. Gilead received a customer complaint and confirmed the presence of a glass particle in

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gilead-issues-voluntary-nationwide-recall-one-lot-veklury-remdesivir-injection-100-mgvial-due

PRAIS 2.0